Myelodysplastic Syndromes (MDS)

High-dose IV ascorbic acid therapy in CCUS patients with TET2 mutations

Original Publication Date
Article Source
External Web Content
This was a phase II trial, evaluating the safety/efficacy of high-dose IV-ascorbic acid in patients with TET2 mutant CCUS. Eight of 10 patients enrolled were eligible for response assessment. At week 20, there were no responses by IWG MDS criteria. NCT03418038 (pdf available at…

Exercise Treatment as Part of Multidisciplinary Whole Person Care in Oncology

Original Publication Date
Article Source
External Web Content
Several national agencies, including the American Society of Clinical Oncology (ASCO), recommend the prescription of exercise for patients diagnosed with cancer.1,2 The evidence base for this recommendation is derived from studies that showed exercise-related improvements in…

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.